← Eichor
Study identifier: NCT06640348 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian Cancer

Condition: Ovarian Cancer, Epithelial  ·  Sponsor: Anhui Provincial Hospital

PhaseN/A
Planned participants70
Who can joinFemale, 18 Years to 70 Years
Healthy volunteersYes

About this study

This project is an open, single-center, prospective study aimed at developing high-sensitivity, high-specificity enrichment SERS chips using femtosecond laser processing technology. It involves extracting information from blood samples of ovarian cancer patients and normal controls, specifically identifying cancer and non-cancer signals. The study will construct a statistical algorithm model for the early diagnosis of ovarian cancer, enabling early identification and intervention for ovarian cancer patients.

This description comes directly from the study's public registry record.

Talk to the study team

Ying Zhou, MD  ·  _8613865901025  ·  caddiezy@ustc.edu.cn

Ying Zhou, MD  ·  caddiezy@ustc.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Anhui Provincal HospitalHefei, Anhui, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06640348